Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Learn how to effectively engage in virtual networking for financial planners to expand your reach and connect with industry experts.
16,067 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
As tariff risk looms into Q3, corporate treasuries are testing prediction markets to hedge potential losses. The move...
Saliva-based tests promise easy disease detection, but coverage gaps and costs could slow adoption. Here’s how it cou...
EOS Energy sparked a fresh rally by expanding into Europe and reporting a production milestone. This article explains...
As DNOW readies its 2025 earnings narrative, investors should focus on backlog, free cash flow, and guidance. This gu...
Choosing between Shift4 Payments and PayPal hinges on your appetite for growth versus stability. This guide breaks do...
The Supreme Court's tariff ruling reshapes costs, consumer prices, and corporate margins. This guide breaks down the ...
Choosing between an energy infrastructure ETF and a clean energy fund comes down to income versus growth and risk. Th...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
May data shows a retail sales surge 0.9%, the strongest in three months, signaling resilience in consumer spending an...
Anthropic's Claude Opus 4.6 launch jolts tech stocks and Bitcoin, signaling a deeper tech-cycle adjustment rather tha...
Wary investors know that waiting for a perfect moment to sell is a recipe for letting losses deepen. Here are four re...